Next-Generation Vaccines and Therapies for Seasonal Influenz

With the end of the national public health emergency for COVID-19 in May 2023, what can be expected as we look ahead to the 2023-2024 influenza season and beyond?

Related Keywords

Australia , Philadelphia , Pennsylvania , United States , Wisconsin , Laos , White House , District Of Columbia , China , Lao , Anthony Fauci , Xavier Becerra , National Institutes Of Health , Bloomberg , National Institute Of Allergy , Cellular Sciences Emphycorp , Human Services , Influenza Hospitalization Surveillance Network , Pfizer , World Health Organization , Us Department Of Health , Products Advisory Committee , Limitations Of Current Vaccine Technology , Advisory Committee On Immunization Practices , Southern Hemisphere , Northern Hemisphere , Hospitalization Surveillance Network , Figure From , Advisory Committee , Immunization Practices , Related Biological Products Advisory Committee , Current Vaccine , Influenza Vaccines , National Institute , Fast Track Designation , Stable From , Gen Biotechnology , Mortal Wkly , Related Biological Products Advisory , Track Designation , Accessed May ,